<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on July 28, 2020</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT03722667</url>
  </required_header>
  <id_info>
    <org_study_id>5P30NR015326-05</org_study_id>
    <nct_id>NCT03722667</nct_id>
  </id_info>
  <brief_title>Technology-based Intervention and Positive Psychological Training for Blood Pressure Control in African Americans</brief_title>
  <acronym>TechSupport</acronym>
  <official_title>The Effects of Technology-based Intervention and Positive Psychological Training on Cognitive Processing and Blood Pressure Control in African Americans</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Case Western Reserve University</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
    <collaborator>
      <agency>University Hospitals Cleveland Medical Center</agency>
      <agency_class>Other</agency_class>
    </collaborator>
  </sponsors>
  <source>Case Western Reserve University</source>
  <oversight_info>
    <has_dmc>Yes</has_dmc>
    <is_fda_regulated_drug>No</is_fda_regulated_drug>
    <is_fda_regulated_device>No</is_fda_regulated_device>
  </oversight_info>
  <brief_summary>
    <textblock>
      The purpose of this pilot study is to evaluate the effects of a theoretically-derived
      technology-based intervention (called TechSuPPorT) and its associated neurological mechanisms
      for hypertension self-management in African Americans.

      The investigators will compare two intervention arms in this study, the Technology-Based
      Component Only arm (comparison group) and the TechSuPPorT arm (intervention group) in 20
      African Americans with uncontrolled hypertension. We aim to:

        1. Determine whether there are differences in blood pressure (BP), health-related quality
           of life (HRQoL), and psychological health (affective well-being, depressive cognitions,
           anxiety) betweenTechSuPPorT and the Technology-based Component only arm.

        2. Determine whether there are differences in self-management behaviors (medication
           adherence, diet, exercise, self-monitoring BP) between the two groups.

        3. Examine whether self-efficacy, decision-making, motivation, patient activation, and
           perceived stress, and positive emotions mediate the relationship between the
           interventions and self-management behaviors.

        4. Determine if social support, demographics (age, gender, education), discrimination, and
           technology utilization moderate self-management behaviors, BP, HRQoL, and psychological
           health.

        5. Explore differences in neural processing (diffusion tensor imaging [DTI]/ task positive
           network [TPN] task-differentiation), and stress response (cortisol and inflammation
           panel) between the two groups.
    </textblock>
  </brief_summary>
  <detailed_description>
    <textblock>
      The investigators will conduct a two-arm randomized clinical trial to compare the effects of
      an Technology-Based Component Only arm and TechSuPPorT on self-management behaviors, BP
      control, and HRQoL outcomeson cognitive task switching between the DMN and TPN neural
      networks using Functional Magnetic Resonance Imaging (fMRI) and Diffusion Tensor Imaging
      (DTI). Both groups will be exposed to the three Technology-based components: (a) six weekly
      web-based modules focused on improving African Americans' knowledge and skills of
      hypertension management; (b) personalized medication adherence support (SMS reminder
      messages, adherence feedback, health and lifestyle tips) through Medisafe, a smartphone app;
      and (c) self-monitor BP with study provided BP monitor. Participants in the TechSuPPorT arm
      will receive the three Technology-based components plus positive psychological training, a
      structured online training and skill building techniques to promote optimism, resilience,
      well-being, and self-confidence.
    </textblock>
  </detailed_description>
  <overall_status>Recruiting</overall_status>
  <start_date type="Actual">October 25, 2018</start_date>
  <completion_date type="Anticipated">July 31, 2019</completion_date>
  <primary_completion_date type="Anticipated">July 31, 2019</primary_completion_date>
  <phase>N/A</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <allocation>Randomized</allocation>
    <intervention_model>Parallel Assignment</intervention_model>
    <intervention_model_description>The investigators hypothesize that African Americans' hypertension self-management behaviors are influenced by the ability of the individual to task differentiate between the DMN and TPN neural processing. Furthermore, such behaviors will lead to improved BP control and HRQoL. Using a two-arm RCT pilot study, investigators will compare the effects of TechSuPPorT and the Technology-based component arm on BP, HRQoL, and psychological health (affective well-being, depressive symptoms, anxiety) and cognitive task differentiation of the DMN and TPN neural networks. Data will be collected at three points: baseline, 8 weeks and 12 weeks. Brain scans (fMRIs) will be captured at baseline and following the intervention at 8 weeks.</intervention_model_description>
    <primary_purpose>Supportive Care</primary_purpose>
    <masking>None (Open Label)</masking>
  </study_design_info>
  <primary_outcome>
    <measure>Change in systolic and diastolic blood pressure</measure>
    <time_frame>Baseline to 8 weeks and 12 weeks</time_frame>
    <description>Measure of participants' in clinic blood pressure (average of three blood pressure readings)</description>
  </primary_outcome>
  <primary_outcome>
    <measure>PROMIS Global Health-10 [health-related quality of life]</measure>
    <time_frame>Baseline to 8 weeks and 12 weeks</time_frame>
    <description>Change in total summed score on PROMIS Global Health-10. Higher scores indicate greater health-related quality of life. Range is 4-20.</description>
  </primary_outcome>
  <primary_outcome>
    <measure>PROMIS Short Form, Positive Affect -15a [positive affect and well-being]</measure>
    <time_frame>Baseline to 8 weeks and 12 weeks</time_frame>
    <description>Change in total summed score on PROMIS Short Form, Positive Affect 15a. Higher scores indicate greater positive affect and well being. Range is 15-45.</description>
  </primary_outcome>
  <primary_outcome>
    <measure>PROMIS- 29, Depression Subscale 4a [depressive symptoms]</measure>
    <time_frame>Baseline to 8 weeks and 12 weeks</time_frame>
    <description>Change in total summed PROMIS-29, Depression Subscale 4a. Higher scores indicate greater depressive symptoms. Range is 4 to 20.</description>
  </primary_outcome>
  <primary_outcome>
    <measure>PROMIS- 29, Anxiety Subscale 4a [anxiety symptoms]</measure>
    <time_frame>Baseline to 8 weeks and 12 weeks</time_frame>
    <description>Change in total summed PROMIS-29, Anxiety subscale. Higher scores indicate greater anxiety. Range is 4-20.</description>
  </primary_outcome>
  <number_of_arms>2</number_of_arms>
  <enrollment type="Anticipated">20</enrollment>
  <condition>Hypertension</condition>
  <condition>Self-management</condition>
  <condition>Technology</condition>
  <arm_group>
    <arm_group_label>Technology-Based Component</arm_group_label>
    <arm_group_type>Placebo Comparator</arm_group_type>
    <description>A Technology-based interventions comprised of three technolgy components accessible via smartphone to support self-managing hypertension.</description>
  </arm_group>
  <arm_group>
    <arm_group_label>TechSupport</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
    <description>A Technology-based interventions comprised of three technolgy components plus positive psychological training accessible by smartphone to support self-managing hypertension.</description>
  </arm_group>
  <intervention>
    <intervention_type>Behavioral</intervention_type>
    <intervention_name>Technology-based Component</intervention_name>
    <description>This intervention is comprised of three technology components: a) six weekly web-based modules focused on improving knowledge and skills to manage hypertension; (b) personalized medication adherence support (SMS reminder messages, adherence feedback, health and lifestyle tips) through Medisafe app; and (c) self-monitoring blood pressure to support self-managing hypertension.</description>
    <arm_group_label>Technology-Based Component</arm_group_label>
  </intervention>
  <intervention>
    <intervention_type>Behavioral</intervention_type>
    <intervention_name>TechSupport</intervention_name>
    <description>The TechSupport intervention is the combination of both an behavioral and emotional intervention.
Technology-based Components: This intervention is comprised of three technology components: a) six weekly web-based modules focused on improving knowledge and skills to manage hypertension; (b) personalized medication adherence support (SMS reminder messages, adherence feedback, health and lifestyle tips) through Medisafe app; and (c) self-monitoring blood pressure to support self-managing hypertension.
Positive Psychological Training (PPT): This intervention will include a structured online training and skill building for PPT accessible by smartphone on techniques to promote optimism, resilience, well-being, and self-confidence.</description>
    <arm_group_label>TechSupport</arm_group_label>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:

          -  self-identify as African American

          -  25 years and older

          -  diagnosed with hypertension defined, as BP â‰¥ 130/80 mmHg

          -  Taking at least one antihypertensive medication(s)

          -  own an android smartphone

          -  able to read and understand English

        Exclusion Criteria:

          -  are unable to give informed consent or judged to have impaired cognitive ability or
             severe memory deficits

          -  currently practicing positive psychological training

          -  have a history of medical conditions or procedures that is contraindicated for fMRI
             scanning (cardiac pacemaker, sternal wires, or metal implants)

          -  have a history of claustrophobia requiring anxiolytics or sedation

          -  pregnant at time of enrollment
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>25 Years</minimum_age>
    <maximum_age>N/A</maximum_age>
    <healthy_volunteers>Accepts Healthy Volunteers</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Carolyn H Still, PhD</last_name>
    <role>Principal Investigator</role>
    <affiliation>University Hospitals Cleveland Medical Center</affiliation>
  </overall_official>
  <overall_contact>
    <last_name>Carolyn H Still, PhD</last_name>
    <phone>216-368-6338</phone>
    <email>cwh11@case.edu</email>
  </overall_contact>
  <location>
    <facility>
      <name>Case Western Reserve University</name>
      <address>
        <city>Cleveland</city>
        <state>Ohio</state>
        <zip>44143</zip>
        <country>United States</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Carolyn Still</last_name>
      <phone>850-321-8807</phone>
      <email>cwh11@case.edu</email>
    </contact>
  </location>
  <location_countries>
    <country>United States</country>
  </location_countries>
  <verification_date>October 2018</verification_date>
  <study_first_submitted>October 25, 2018</study_first_submitted>
  <study_first_submitted_qc>October 25, 2018</study_first_submitted_qc>
  <study_first_posted type="Actual">October 29, 2018</study_first_posted>
  <last_update_submitted>October 25, 2018</last_update_submitted>
  <last_update_submitted_qc>October 25, 2018</last_update_submitted_qc>
  <last_update_posted type="Actual">October 29, 2018</last_update_posted>
  <responsible_party>
    <responsible_party_type>Principal Investigator</responsible_party_type>
    <investigator_affiliation>Case Western Reserve University</investigator_affiliation>
    <investigator_full_name>Carolyn Still</investigator_full_name>
    <investigator_title>Assistant Professor, Frances Payne Bolton School of Nursing</investigator_title>
  </responsible_party>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Hypertension</mesh_term>
  </condition_browse>
  <patient_data>
    <sharing_ipd>Undecided</sharing_ipd>
  </patient_data>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

